Pages that link to "Q35108500"

The following pages link to Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan (Q35108500):

Displaying 19 items.

• Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use (Q26747823) (← links)
• Clinical applications of hallucinogens: A review (Q34535259) (← links)
• Investigational drugs for treating major depressive disorder (Q34547274) (← links)
• Investigational drugs in recent clinical trials for treatment-resistant depression (Q34549390) (← links)
• Sigma-1 Receptor Antagonist BD1047 Reduces Mechanical Allodynia in a Rat Model of Bone Cancer Pain through the Inhibition of Spinal NR1 Phosphorylation and Microglia Activation (Q36367024) (← links)
• Dextromethorphan/quinidine: a review of its use in adults with pseudobulbar affect (Q38270903) (← links)
• Recreational use of dextromethorphan, "Robotripping"-A brief review (Q38861873) (← links)
• What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities. (Q39006234) (← links)
• AVP-786 for the treatment of agitation in dementia of the Alzheimer's type (Q39034436) (← links)
• Behavioral and biochemical effects of ketamine and dextromethorphan relative to its antidepressant-like effects in Swiss Webster mice (Q39435750) (← links)
• A behavioral and pharmacological characterization of palatable diet alternation in mice (Q46269870) (← links)
• NMDAR antagonists for the treatment of diabetes mellitus-Current status and future directions. (Q47961234) (← links)
• The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases (Q50973291) (← links)
• Identification and in vivo Efficacy Assessment of Approved Orally Bioavailable Human Host Protein-Targeting Drugs With Broad Anti-influenza A Activity. (Q64883386) (← links)
• Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates (Q89690209) (← links)
• Potential Negative Effects of Dextromethorphan as an Add-On Therapy to Methylphenidate in Children With ADHD (Q92105695) (← links)
• Dextromethorphan and memantine after ketamine analgesia: a randomized control trial (Q92855889) (← links)
• Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments (Q93177074) (← links)
• Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis (Q99612569) (← links)